Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers
Introduction
Deletions of chromosome 3p have been consistently reported for a number of tumor types, including lung cancer. The frequency of loss of 3p is close to 100% for small cell lung cancer and approximately 70% for non-small cell lung cancer 1, 2. In addition, 3p deletions are among the earliest recognized changes in lung cancer, and have been observed in preinvasive bronchial lesions 3, 4. The consistency and early appearance of loss of heterozygosity (LOH) on chromosome 3p in lung cancer as well as other tumor types suggests that this region may harbor one or more tumor suppressor genes.
Chromosome transfer experiments using chromosome 3 support the conclusion from LOH studies that chromosome 3p carries a tumor suppressing function for lung, renal and oral carcinomas. Tumorigenicity was shown to be reduced in human lung adenocarcinoma cells by transfer of chromosomes 3 and 11 [5]; in a mouse fibrosarcoma cell line by transfer of a 2-Mb fragment from 3p21 [6]; and by transfer of a normal chromosome 3p to a human renal carcinoma cell line [7]and to oral carcinoma cell lines [8]. Recently, it was shown that introduction of an 80-kb P1 clone from 3p21.3 was able to suppress tumorigenicity of a mouse fibrosarcoma cell line following injection of the transfected cells into athymic nude mice [9].
The frequency of allelic loss of chromosome 3p21.3 sequences in lung tumors, the early occurrence of these events and the finding of similar losses in other types of cancer, provide strong evidence that there are 3p21.3 genes which have important and fundamental roles in the maintenance of normal cellular growth. Detailed mapping of 3p deletions indicates that at least three discrete regions, located around 3p14, 3p21 and 3p25, are involved and may contain loci for tumor suppressor genes 10, 11, 12, 13. In this report, we show that the smallest region of deletion overlap in a number of non-small cell lung carcinomas involves the marker D3S32, located at 3p21.3. We have identified the human homolog of the L14 ribosomal protein gene (RPL14), and used genetic mapping to localize the coding sequence to 3p21.3. RPL14 contains a polymorphic CTG repeat encoding a polyalanine tract. Polyalanine regions are found in a number of genes of developmental significance, consistent with the regulatory roles reported for ribosomal proteins.
Section snippets
Growth of cell lines
Epithelial cells from bronchial biopsies and primary lung tumors were cultured as described [14].
3p heterozygosity analysis
Loss of heterozygosity was determined for loci located on the short arm of chromosome 3 in 16 NSCLC primary tumors, cell lines and in non-malignant tissue immediately adjacent to tumors. Loci which were analyzed included: THRB, D3S647, D3S1076, D3S688, D3S32, D3F15S2, D3S1029, D3S2, D3S717, D3S6, D3S30 and D3S3.
cDNA cloning and sequencing
Clone 7DE, a fragment of RPL14 containing 13 copies of the CTG trinucleotide repeat, was
Identification of cDNA clones
In a search for novel genes involved in lung cancer, we identified and cloned a cDNA fragment containing 13 copies of a CTG repeat. This gene was subsequently found to be the human homolog of the gene for ribosomal protein L14 (RPL14) based on 88% homology to the previously characterized R. norvegicus ribosomal protein L14 21, 22. Additonal database comparison showed that a portion of this sequence had first been identified in a scan for trinucleotide repeat-containing genes expressed in the
Discussion
We have shown that the RPL14 gene is located within 3p21.3 adjacent to the marker D3S32. This marker has been found to be deleted at high frequency in lung tumors, and is within the smallest region of deletion overlap observed in NSCLC. RPL14 contains a highly polymorphic CTG repeat encoding a polyalanine tract. A number of studies have been reported which focused on the identification of new genes containing trinucleotide repeats. A portion of RPL14 is 93% homologous to clone B33, which was
Acknowledgements
The authors wish to thank Dr. Jennifer Grandis for SCCHN RNA samples, and Autumn Gaither Davis and Amy Marcini for excellent technical assistance. This work was supported by IRG-58-34 from the American Cancer Society to S.P.S. and SPORE in lung cancer (NIH) P20 CA58235 to J.M.S.
References (76)
- et al.
Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung
Lung Cancer
(1994) - et al.
Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes
Adv. Cancer Res.
(1997) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction
Anal. Biochem.
(1987) - et al.
The primary structure of rat ribosomal protein RPL14
Biochem. Biophys. Res. Commun.
(1996) - et al.
Triplet repeat-containing ribosomal protein L14 gene in immortalized human endothelial cell line (t-HUE4)
Biochem. Biophys. Res. Commun.
(1998) - et al.
Novel triplet repeat-containing genes in human brain: cloning, expression and length polymorphisms
Genomics
(1993) Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE
Methods Enzymol.
(1993)- et al.
Loss of 3p or 11p is associated with testicular cancer tumors
Genomics
(1989) - et al.
Renal cell carcinoma: molecular genetics and clinical implications
Adv. Urolog. Oncol.
(1995) - et al.
Hereditary papillary renal cell carcinoma
J. Urology
(1994)
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
Cell
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Cell
Identification of a gene (FMR-1) containing CGG repeat coincident with a breakpoint cluster region exhibiting length variation in Fragile X syndrome
Cell
Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation
Cell
Gsh-2, a murine homeobox gene expressed in the developing brain
Mech. Dev.
What determines the specificity of action of Drosophila homeodomain proteins?
Cell
The L19 ribosomal protein gene (RPL19): Gene organization, chromosomal mapping, and novel promoter region
Genomics
Extraribosomal functions of ribosomal proteins
Trends Biochem. Sci.
The S3a ribosomal protein gene is identical to the Fte-1 (v-fos transformation effector) gene and the TNF-alpha-induced TU-11 gene, and its transcript level is altered in transformed and tumor cells
Gene
Constitutive expression of human ribosomal protein L7 arrests the cell cycle in G1 and induces apoptosis in Jurkat T-lymphoma cells
Exp. Cell Res.
Drosophila ribosomal protein S3 contains an activity that cleaves DNA at apurinic/apyrimidinic sites
J. Biol. Chem.
The primary structure of rat ribosomal protein L10: relationship to a Jun-binding protein and to a putative Wilms' tumor suppressor
Biochem. Biophys. Res. Commun.
Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small cell lung cancer
Int J. Cancer
Sequential molecular genetic changes in lung cancer development
Oncogene
The molecular and cellular basis of human lung cancer
Anticancer Res.
Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer
Mol. Carcinog.
Definition of a tumor suppressor locus within human chromosome 3p21-p22
Proc. Natl. Acad. Sci. U.S.A.
Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR
Oncogene
Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer
Oncogene
An 80-kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo
Oncogene
A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
Oncogene
Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung
Cancer Res.
Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity
Cancer Res.
Detection of human lung epithelial growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors
Cancer Res.
Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization
Nucleic Acids Res.
Isolation and mapping of a polymorphic DNA sequence (pEFD145) on chromosome 3 [D3S32]
Nucleic Acids Res.
A technique for radiolabelling DNA restriction endonuclease restriction fragments to high specific activity
Anal. Biochem.
Cited by (31)
Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms
2007, Otolaryngology - Head and Neck SurgeryCitation Excerpt :On the other hand, concerning 3p21.3 apart from FHIT loci, the loss of chromosome 3 common eliminated region 1 (C3CER1) has been defined during tumor formation of microcell hybrids in SCID mice.9 And human ribosomal protein L14 (RPL14), located close to D3S966, has also been demonstrated to have high LOH in lung cancer and HNSCC.10 Recently, RPL14 with regulatory roles in transcription was found to be down-regulated in esophageal squamous cell carcinomas.11
Cloning and characterization of 40S ribosomal protein S4 gene from Culex pipiens pallens
2007, Comparative Biochemistry and Physiology - B Biochemistry and Molecular BiologyAlteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus
2006, GeneCitation Excerpt :PCR on the DNA samples was performed using the sense 5′-AAG CAC CTG GTA CTA AGG GTA-3′ and antisense 5′-TCG CGG CGG TGA TCT TTT TTG-3′ primers as described previously (Shriver et al., 1998).
Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma
2003, Head and Neck Cancer: Emerging PerspectivesInhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product
2001, Cellular Signalling